Multidisciplinary Management of Fabry Disease: Current Perspectives

Multidisciplinary Management of Fabry Disease: Current Perspectives

Luciana Paim-Marques,1 Rodrigo Joel de Oliveira,2 Simone Appenzeller2 1Department of Pediatrics, University of Florida, Gainesville, FL, USA; 2Department of Orthopedics, Rheumatology and Traumatology- School of Medical Sciences and University of Campinas (UNICAMP), São Paulo, BrazilCorrespondence: S...

Full description

Bibliographic Details
Main Authors:	Paim-Marques L, de Oliveira RJ, Appenzeller S
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-03-01
Series:	Journal of Multidisciplinary Healthcare
Subjects:	fabry disease multidisciplinary care alfa-galactosidase.
Online Access:	https://www.dovepress.com/multidisciplinary-management-of-fabry-disease-current-perspectives-peer-reviewed-fulltext-article-JMDH

Similar Items

Might Be Fabry Disease?
by: Aysegul Oruc
Published: (2020-01-01)

Screening for Fabry Disease in Left Ventricular Hypertrophy: Documentation of a Novel Mutation
by: Ana Baptista, et al.
Published: (2015-01-01)

Doença de Fabry Fabry disease
by: Paula Boggio, et al.
Published: (2009-08-01)

Fabry disease: clinical and genotypic aspects of three cases in first degree relatives
by: Leticia Bueno Nunes da Silva, et al.
Published: (2014-01-01)

Clinical heterogeneity in Fabry disease: A clinical case
by: Assel Issabekova, et al.
Published: (2023-08-01)

Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis
by: Taciane Alegra, et al.
Published: (2012-01-01)

When should we think about Fabry disease?
by: Natalia Chojnacka, et al.
Published: (2024-01-01)

Fabry’s Disease: The Utility of a Multidisciplinary Screening Approach
by: Marco Angelo Monte, et al.
Published: (2022-04-01)

Characterization of small fiber pathology in a mouse model of Fabry disease
by: Lukas Hofmann, et al.
Published: (2018-10-01)

Fabry disease exacerbates renal interstitial fibrosis after unilateral ureteral obstruction via impaired autophagy and enhanced apoptosis
by: Sungjin Chung, et al.
Published: (2021-06-01)

The coincidence of IgA nephropathy and Fabry disease
by: Maixnerová Dita, et al.
Published: (2013-01-01)

Screening for Fabry Disease in Kidney Transplant Recipients: Experience of a Multidisciplinary Team
by: Massimiliano Veroux, et al.
Published: (2020-10-01)

Fabry Disease - literature review
by: Krystian Wdowiak, et al.
Published: (2024-11-01)

Fabry disease, a complex pathology not easy to diagnose
by: Paolo Colomba, et al.
Published: (2015-12-01)

Enfermedad de Fabry, a propósito de un caso interesante
by: Irelys González López, et al.

Enzyme Replacement Therapy in the Treatment of Fabry Disease
by: YU Che, et al.
Published: (2023-07-01)

The Role of Cardiac MRI in the Diagnosis of Fabry Disease
by: Yoo Jin Hong, et al.
Published: (2020-03-01)

Il DBS come test diagnostico nella malattia di Fabry
by: Simone Scalia
Published: (2017-07-01)

Correlation of X chromosome inactivation with clinical presentation of Fabry disease in a case report
by: Pablo Rodríguez Doyágüez, et al.
Published: (2023-12-01)

Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease
by: Takahiro Tsukimura, et al.
Published: (2014-01-01)

Case report: is low α-Gal enzyme activity sufficient to establish the diagnosis of Fabry disease?
by: Gilson Biagini, et al.

Fabry disease: Mechanism and therapeutics strategies
by: Xi Li, et al.
Published: (2022-10-01)

THE FEATURES OE CLINICAL AND LABORATORY DIAGNOSIS OF FABRY DISEASE
by: N O. Pichkur
Published: (2017-12-01)

La malattia di Anderson-Fabry. Introduzione
by: Giovanni Duro, et al.
Published: (2017-07-01)

Fabry disease presenting with renal disease as the main manifestation diagnosed by renal biopsy: a case report
by: HAO Xu, WANG Weiming
Published: (2022-08-01)

The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia
by: Andrew Mallett, et al.
Published: (2020-02-01)

Females with Fabry disease: an expert opinion on diagnosis, clinical management, current challenges and unmet needs
by: Antonino Tuttolomondo, et al.
Published: (2025-03-01)

Anderson-Fabry: una malattia rara?
by: Paolo Colomba, et al.
Published: (2015-06-01)

Parkinson's disease prevalence in Fabry disease: A survey study
by: Adina H. Wise, et al.
Published: (2018-03-01)

An Overview of Molecular Mechanisms in Fabry Disease
by: Federica Amodio, et al.
Published: (2022-10-01)

Multiple phenotypic domains of Fabry disease and their relevance for establishing genotype–phenotype correlations
by: Oliveira JP, et al.
Published: (2019-03-01)

Strong increase of leukocyte apha‐galactosidase A activity in two male patients with Fabry disease following oral chaperone therapy
by: Foudil Lamari, et al.
Published: (2019-09-01)

Evaluating the Metabolic Basis of α-Gal A mRNA Therapy for Fabry Disease
by: Zhendong Zhang, et al.
Published: (2024-02-01)

NEUROLOGICAL MANIFESTATIONS OF FABRY DISEASE IN CHILDREN AND ADOLESCENTS
by: A. S. Kotov, et al.
Published: (2017-12-01)

Genomic analysis of Brazilian patients with Fabry disease
by: F.S. Pereira, et al.
Published: (2007-12-01)

Description of a New GLA Gene Variant in a Patient with Hypertrophic Cardiomyopathy. Is it Fabry Disease?
by: Marcelo Imbroinise Bittencourt

Anderson–Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?
by: Marialuisa Zedde, et al.
Published: (2022-12-01)

La malattia di Anderson-Fabry. Conclusioni
by: Giovanni Duro, et al.
Published: (2017-07-01)

Fabry disease: Four case reports of meningioma and a review of the literature on other malignancies
by: Beth L. Thurberg, MD, PhD, et al.
Published: (2017-06-01)

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
by: Michael Beck, et al.
Published: (2015-06-01)